In vitro release of fusidic acid and teicoplanin from cancellous bone allografts

Journal of Chemotherapy

Volumn 20, Issue 5, 2008, Pages 645-647

  Kanellakopoulou, K ^a   Sahinides, T ^b   Tsaganos, T ^a   Galanakis, N ^b   Giamarellou, H ^a   Giamarellos Bourboulis, E J ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b St Panteleimon Hospital   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cancellous bone; Drug release; Fusidic acid; Teicoplanin

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; FUSIDIC ACID; TEICOPLANIN;

ARTICLE; BONE ALLOGRAFT; CANCELLOUS BONE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG INDICATION; DRUG RELEASE; ELUTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MICROBIOLOGY; OSTEOMYELITIS;

EID: 57049110572     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.5.645     Document Type: Article

References (15)

1. Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin North Amer 2005;19: 765-786
2. Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 2000; 59:1223-1232
3. Buttaro M, Cornba F, Piccaluga F. Vancomycin-supplemented cancellous bone allografts in hip revision surgery. Clin Orthop Relat Res. 2007; 461: 74-80
4. Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006; 66: 1089-105
5. Kuti JL, Killer CR, Mendes CM, Nicolau DP. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Clin Microbiol Infect 2008; 14: 116-123
6. Witsø E, Persen L, Benum P, Bergh K. Release of netilmicin and vancomycin from cancellous bone. Acta Orthop Scand 2002; 73: 199-205
7. Winkler H, Janata O, Berger C, Wein W, Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 2000; 46: 423-428
8. Witsø E, Persen L, Løseth K, Benum P, Bergh K. Cancellous bone as an antibiotic carrier. Acta Orthop Scand 2000; 71: 80-84
9. Buttaro MA, Pusso R, Piccaluga F. Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br 2005; 87: 314-319
10. Buttaro MA, Morandi A, Rivello HG, Piccaluga F. Histology of vancomycin-supplemented impacted bone allografts in revision total hip arthroplasty. J Bone Joint Surg Br 2005; 87: 1684-1687
11. Chen CE, Ko JY, Pan CC. Results of vancomycin-impregnated cancellous bone grafting for infected tibial nonunion. Arch Orthop Trauma Surg 2005; 125: 369-375
12. Chan YS, Ueng SW, Wang CJ, Lee SS, Chen CY, Shin CH. Antibiotic-impregnated autogenic cancellous bone grafting is an effective and safe method for the management of small infected tibial defects: a comparison study. J Trauma 2000; 48: 246-255
13. Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, Ghisellini F, Ritter MA. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty 2002; 17: 619-626
14. Bogdanovich T, Ednie LM, Shapiro S, Appelbaum PC. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 2005; 49: 4210-4219
15. Wilson AP, Cepeda JA, Hayman S, Whitehouse T, Singer M, Bellingan G. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients. J Antimicrob Chemother 2006; 58: 470-473